Associated Papers
Exonic Variation in HLA-C, CFB, and TAP2 Associated With Increased Risk for Comorbid Crohn's Disease and Psoriasis.
Shaw VR et al.
International Journal of Dermatology, 2025
The HLA-C*12:72 Allele, Confirmed by Next-Generation Sequencing in an Indian Individual.
Agarwal S et al.
Hla, 2025
Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma.
Versluis JM et al.
Cancer Immunology, Immunotherapy : Cii, 2024
Class I MHC Polymorphisms Associated with Type 2 Diabetes in the Mexican Population.
Mendoza-Ramírez P et al.
Genes, 2022
35627158 (PubMed )
Supplement: genes-13-00772-s001.zip › genes-1649373-supplementary.pdf
Characterization of the novel HLA-C*01:154 allele by polymerase chain reaction sequencing-based typing.
You X et al.
Hla, 2020
Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.
Calender A et al.
Bmc Medical Genomics, 2018
29510755 (PubMed )
Supplement: 12920_2018_338_MOESM6_ESM.xlsx › T1
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Tang X et al.
Nucleic Acids Research, 2014
25352556 (PubMed )
Supplement: supp_gku1005_nar-01266-met-n-2014-File012.xlsx › TCGA-A2-A0CT-01A.domain
Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements.
Egan JB et al.
Plos One, 2014
24505276 (PubMed )
Supplement: pone.0087113.s004.xls › Table_S3
Select a paper to view details